Acquisitions27 Feb 2026, 10:02 am
Essix Biosciences Acquires 51 Lakh Shares of Ind-Swift Laboratories via Fully Convertible Warrants
AI Summary
Essix Biosciences Limited, on behalf of the promoter and promoter group of Ind-Swift Laboratories Limited, has acquired 51,00,000 Equity Shares of Ind-Swift Laboratories on February 24, 2026. The acquisition was made pursuant to the conversion of Fully Convertible Warrants into Equity Shares. The total voting rights of Essix Biosciences Limited now stands at 40.05% post-acquisition.
Key Highlights
- Essix Biosciences acquires 51 Lakh shares of Ind-Swift Laboratories
- Acquisition made pursuant to the conversion of Fully Convertible Warrants into Equity Shares
- Essix Biosciences' voting rights stand at 40.05% post-acquisition